NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球生物外科市場(~ 2026 年):產品類型(密封劑、止血劑、粘合屏障、軟組織附件、生物網、DBM、骨移植替代品)、應用(骨科、心血管)、最終用戶(醫院)□診所)□按地區

Biosurgery Market by Product Type (Sealants, Hemostats, Adhesion Barrier, Soft Tissue Attachments, Biological Meshes, DBM, Bone Graft Substitutes), Application (Orthopedic, Cardiovascular), End User (Hospitals, Clinics) - Global Forecast to 2026

出版商 MarketsandMarkets 商品編碼 1015681
出版日期 內容資訊 英文 376 Pages
訂單完成後即時交付
價格
全球生物外科市場(~ 2026 年):產品類型(密封劑、止血劑、粘合屏障、軟組織附件、生物網、DBM、骨移植替代品)、應用(骨科、心血管)、最終用戶(醫院)□診所)□按地區 Biosurgery Market by Product Type (Sealants, Hemostats, Adhesion Barrier, Soft Tissue Attachments, Biological Meshes, DBM, Bone Graft Substitutes), Application (Orthopedic, Cardiovascular), End User (Hospitals, Clinics) - Global Forecast to 2026
出版日期: 2021年06月21日內容資訊: 英文 376 Pages
簡介

在預測期內,生物外科市場預計將以 5.7% 的複合年增長率增長,從 2021 年的 122 億美元增長到 2026 年的 160 億美元。...

需要手術的慢性疾病和嚴重創傷的增加、對有效出血管理的需求增加以及先進生物外科產品的可用性增加等因素推動了市場的增長。我有。另一方面,高產品成本、缺乏專家和嚴格的監管框架等挑戰預計將阻礙市場的進一步增長。

從產品來看,骨移植替代品行業在 2020 年的份額最大。儘管自體移植是骨缺損的標準治療方法,但它有各種局限性,包括潛在的感染風險和供體部位的發病率。因此,人們越來越關注新的生物材料。此外,通過使用植骨替代物,不需要進行二次手術,手術部位不需要額外的切口,從而形成脫鈣骨基質、合成植骨、同種異體植骨和骨形態。全球骨科和牙科手術中越來越多地採用蛋白質等骨移植替代品。

本報告探討了全球生物外科市場、市場定義和概述、價值鏈、大流行性冠狀病毒感染 (COVID-19) 分析和其他市場影響因素、監管環境,總結了技術/專利的趨勢、變化/預測市場規模、按產品/應用/最終用戶/地區/主要國家、競爭環境、主要公司概況等細分。

第 1 章介紹

第 2 章調查方法

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章市場概覽

  • 市場動態
    • 市場增長因素
    • 市場抑制因素
    • 市場機會
    • 市場問題

第 6 章產業考量

  • 行業趨勢
  • 監管分析
  • 波特五力分析
  • 價格分析
  • 技術分析
  • 生態系統分析
  • 價值鏈分析
  • 專利分析
  • COVID-19 的影響

第 7 章市場分析/預測:按產品

  • 骨移植替代品
    • 脫鈣骨基質
    • 合成骨移植物
    • 骨形態發生蛋白
    • 其他
  • 軟組織附著
    • 合成網格
    • 生物網格
  • 止血劑
    • 凝血□基礎
    • 氧化再生纖維素基質
    • 複合止血劑
  • 手術密封膠/粘合劑
    • 天然和生物材料
    • 合成/半合成
  • 黏附屏障
    • 合成
    • 天然
  • 訂書釘線加固

第 8 章市場分析/預測:按應用

  • 骨科
  • 普通外科
  • 神經外科
  • 心血管外科
  • 重建手術
  • 婦科手術
  • 泌尿外科
  • 胸部手術
  • 其他

第 9 章市場分析/預測:按最終用戶

  • 醫院
  • 診所
  • 其他

第 10 章市場分析/預測:按地區/主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第 11 章競爭形勢

  • 概述
  • 大公司的戰略
  • 主要公司的收入份額分析
  • 市場份額分析
  • 競爭基準
  • 競爭領導力圖
  • 初創企業的競爭領導力圖
  • 競爭場景

第 12 章公司簡介

  • 主要公司
    • BAXTER INTERNATIONAL INC.
    • B. BRAUN MELSUNGEN AG
    • BECTON, DICKINSON & COMPANY
    • JOHNSON & JOHNSON
    • MEDTRONIC PLC
    • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
    • COMMONWEALTH SERUM LABORATORIES LIMITED
    • HEMOSTASIS LLC
    • PFIZER INC.
    • STRYKER CORPORATION
    • CRYOLIFE, INC.
    • ZIMMER BIOMET
    • KUROS BIOSCIENCES AG
    • ORTHOFIX MEDICAL INC.
    • SMITH & NEPHEW PLC
    • TISSUE REGENIX GROUP PLC
    • BETATECH MEDICAL
    • MERIL LIFE SCIENCES PVT. LTD.
    • RTI SURGICAL
    • SAMYANG HOLDINGS CORPORATION
  • 其他龍頭企業
    • AROA BIOSURGERY LTD.
    • MEYER-HAAKE GMBH
    • BIOM'UP
    • BIOCER ENTWICKLUNGS-GMBH
    • HANNOX INTERNATIONAL CORP.

第 13 章附錄

目錄
Product Code: MD 3554

The biosurgery market is projected to reach USD 16.0billion by 2026 from USD 12.2billion in 2021, at a CAGR of 5.7% during the forecast period. Growth in this market is majorly driven by the growing prevalence of chronic diseases requiring surgical interventions and severe traumatic injuries. Owing to increasing growth in such incidence, the volume of elective surgical procedures is increasing, which is driving the demand for biosurgery products. In addition, rising demand for effective blood loss management and increasing availability of advanced biosurgery products is also helping to back the market growth. However, high cost of biosurgery products, dearth of skilled professionals, and stringent regulatory framework are expected to hamper the growth of this market during the forecast period.

Based on product, the bone graft substitutes holds the largest market share during the forecast period.

Based on the product, the bone graft substitutes segment accounted for the largest share of the global biosurgery market in 2020. Bone-graft substitutes are alternative products to autografts and possess osteoconductive properties. Although autografts are used as the gold standard for the treatment of bone defects, they have various limitations, such as the potential risk of infections and donor site morbidity. As a result, the focus on new orthobiologic materials like synthetic bone-graft substitutes is increasing. Moreover, the use of bone graft substitutes eliminates the need for a second operative procedure and an extra incision at the site of the surgery. As a result, the adoption of bone graft substitutes such as demineralized bone matrix, synthetic bone grafts, allografts, and bone morphogenetic proteins is increasing across orthopedic and dental surgeries globally.

Based onapplication, thereconstructive surgery segment is expected to register the highest CAGR during the forecast period.

The reconstructive surgery in the application segment is expected to show the highest growth rate during the forecast period. Surgical sealants, hemostats, soft-tissue patches/meshes, and staple line reinforcement agents are extensively used in various reconstructive surgeries, including plastic surgeries, facelifts, rhinoplasty, body contouring, breast surgeries (breast reconstruction & augmentation), burns, and craniofacial applications. Rising number of surgical reconstructive procedures such as facial reconstruction and minimally invasive cosmetic procedures, increasing incidence of skin injuries, growing incidence of burn injuries, and the increasing number of breast cancer patients undergoing mastectomy and breast reconstruction procedures are driving the rapid adoption of biosurgery products in the reconstructive surgery segment.

Based on end-user, the hospitals segment holds the largest market share during the forecast period.

The biosurgery market is segmented into hospitals, clinics,and others. The hospital segment dominates the market share in 2020. The biosurgery products are extensively used in hospitals across operating rooms during surgeries. Moreover, the use of soft-tissue attachments and bone-graft substitutes (such as DBM and BMP) is increasing across hospitals to reduce the duration of patient stays and enhance the healing process. Bone-graft substitutes are finding use as osteoconductive and osteoinductive materials, specifically across orthopedic and spinal procedures. Similarly, hemostatic agents and adhesion barriers are finding increasing adoption across abdominal and cardiovascular procedures to prevent post-operative complications. Moreover, the number of hospitals is increasing globally, especially in emerging countries, which is supporting the high revenue growth in the segment.

North America accounted for the largest share of the biosurgerymarket in 2020

In 2020, North America accounted for the largest share of the biosurgerymarket, followed by Europe, Asia Pacific, Latin America, and Middle East & Africa. The large share of this market segment can be attributed to the presence of a significant number of prominent vendors, a highly developed healthcare system, increasing volume of elective surgeries, rising prevalence of chronic diseases, and favorable reimbursement policies for biosurgery products.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-35%, Tier 2-45%, and Tier 3-20%
  • By Designation - C-level-35%, Director-level-25%, Others-40%
  • By Region - North America-45%, Europe-30%, AsiaPacific-20%, Latin America- 3%, Middle East and Africa-2%

Key players in the biosurgery market

The key players operating in the biosurgerymarketinclude Johnson & Johnson (US), Baxter International Inc. (US), Medtronic Plc (Ireland), Becton, Dickinson & Co. (US), B. Braun Melsungen AG (Germany), Stryker Corp. (US), Integra Lifesciences Holdings Corp. (US), CSL Ltd. (Australia), Hemostasis LLC. (US), Pfizer Inc. (US), Cyrolife Inc. (US), Zimmer Biomet (US), Kuros Biosciences AG (Switzerland), Orthofix Medical Inc. (US), Smiths & Nephew Plc. (UK).

Research Coverage:

The report analyzes the biosurgerymarketand aims at estimating the market size and future growth potential of this market based on various segments such asproduct, application, end user,andregion. The report also includes aproduct portfolio matrix of various biosurgery productsavailable in the market. The report also providesa competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would helpthem, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies tostrengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global biosurgerymarket. The report analyzes this marketbyproduct, application, and end user
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and productlaunches in the global biosurgerymarket
  • Market Development: Comprehensive information on the lucrative emerging markets by product, application, and end user
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in theglobal biosurgerymarket
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in theglobal biosurgerymarket.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION & SCOPE
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKET SEGMENTATION
    • FIGURE 1 BIOSURGERY MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
  • 2.2 RESEARCH METHODOLOGY DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Insights from primary experts
      • 2.2.2.3 Breakdown of primary interviews: Supply-side and demand-side participants
      • 2.2.2.4 Breakdown of primary interviews: By company, designation, and region
  • 2.3 MARKET SIZE ESTIMATION: BIOSURGERY MARKET
    • FIGURE 3 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 4 REVENUE SHARE ANALYSIS ILLUSTRATION-BAXTER INTERNATIONAL, INC.
    • FIGURE 5 REVENUE ANALYSIS OF THE TOP 3 PUBLIC COMPANIES: SURGICAL SEALANTS AND ADHESIVES SEGMENT (2020)
    • FIGURE 6 BOTTOM-UP APPROACH-SEGMENTAL EXTRAPOLATION
    • FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE BIOSURGERY MARKET (2021-2026)
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 ASSUMPTIONS FOR THE STUDY
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: BIOSURGERY MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 10 BIOSURGERY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 BIOSURGERY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 BIOSURGERY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE BIOSURGERY MARKET

4 PREMIUM INSIGHTS

  • 4.1 BIOSURGERY MARKET OVERVIEW
    • FIGURE 14 INCREASING NEED TO MANAGE BLOOD LOSS IN PATIENTS AND FOCUS ON THE LAUNCH OF NEW PRODUCTS TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: BIOSURGERY MARKET FOR NATURAL SEALANTS & ADHESIVES, BY TYPE AND COUNTRY (2020)
    • FIGURE 15 FIBRIN-BASED SEALANTS & ADHESIVES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020
  • 4.3 BIOSURGERY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 16 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
  • 4.4 BIOSURGERY MARKET, BY REGION (2019-2026)
    • FIGURE 17 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BIOSURGERY MARKET DURING THE FORECAST PERIOD
  • 4.5 BIOSURGERY MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 18 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Increasing volume of surgeries and growing prevalence of severe trauma injuries
    • TABLE 2 UK: INCREASE IN THE NUMBER OF CARDIAC SURGICAL PROCEDURES PERFORMED
      • 5.2.1.2 Strong focus on R&D leading to the launch of technologically advanced products
      • 5.2.1.3 Rising need for effective blood loss management in patients
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 High price of biosurgery products and the rising cost of surgical procedures
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Growing use of combination materials for enhancing product efficacy
      • 5.2.3.2 Growing adoption of advanced biosurgery products in emerging markets
    • TABLE 3 COST OF SURGICAL PROCEDURES: US VS. INDIA (USD)
      • 5.2.3.3 Growing adoption of adhesive dentistry procedures
    • 5.2.4 MARKET CHALLENGES
      • 5.2.4.1 Stringent regulatory framework
      • 5.2.4.2 Requirement of skilled personnel for the effective use of biosurgery products

6 INDUSTRY INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 INDUSTRY TRENDS
    • 6.2.1 GROWING FOCUS ON ORGANIC GROWTH STRATEGIES
    • TABLE 4 NUMBER OF PRODUCT LAUNCHES BY KEY PLAYERS (JANUARY 2018 TO JUNE 2021)
    • 6.2.2 GROWING DEMAND FOR DENTAL BONE-GRAFT SUBSTITUTES
    • 6.2.3 GROWING PREFERENCE FOR GELATIN-BASED ADHESIVES & HYDROGELS IN SURGICAL PROCEDURES
    • 6.2.4 USE OF NANOTECHNOLOGY FOR DEVELOPING NEXT-GENERATION ADHESIVES
  • 6.3 REGULATORY ANALYSIS
    • TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING BIOSURGERY PRODUCTS
    • 6.3.1 NORTH AMERICA
      • 6.3.1.1 US
    • TABLE 6 US FDA: CLASSIFICATIONS OF MEDICAL DEVICES
    • FIGURE 19 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES
      • 6.3.1.2 Canada
    • FIGURE 20 CANADA: CLASS III MEDICAL DEVICES APPROVAL PROCESS
    • 6.3.2 EUROPE
    • FIGURE 21 EUROPE: CE APPROVAL PROCESS FOR BIOSURGERY PRODUCTS
    • 6.3.3 ASIA PACIFIC
      • 6.3.3.1 Japan
    • TABLE 7 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY
      • 6.3.3.2 China
    • TABLE 8 NMPA MEDICAL DEVICES CLASSIFICATION
      • 6.3.3.3 India
    • TABLE 9 INDIA: CLASSIFICATION OF BIOSURGERY PRODUCTS
  • 6.4 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 10 PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1 THREAT OF NEW ENTRANTS
    • 6.4.2 THREAT OF SUBSTITUTES
    • 6.4.3 BARGAINING POWER OF SUPPLIERS
    • 6.4.4 BARGAINING POWER OF BUYERS
    • 6.4.5 INTENSITY OF COMPETITIVE RIVALRY
  • 6.5 PRICING ANALYSIS
    • TABLE 11 AVERAGE SELLING PRICE FOR BIOSURGERY PRODUCTS
  • 6.6 TECHNOLOGY ANALYSIS
  • 6.7 ECOSYSTEM ANALYSIS
    • FIGURE 22 BIOSURGERY MARKET: ECOSYSTEM ANALYSIS
  • 6.8 VALUE CHAIN ANALYSIS
    • FIGURE 23 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE
  • 6.9 PATENT ANALYSIS
    • 6.9.1 PATENT PUBLICATION TRENDS FOR BIOSURGERY
    • FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2011-JUNE 2021)
    • 6.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR BIOSURGERY PATENTS (JANUARY 2011 TO JUNE 2021)
    • FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR BIOSURGERY PATENTS (JANUARY 2011 TO JUNE 2021)
    • TABLE 12 LIST OF FEW PATENTS IN THE BIOSURGERY MARKET, 2020-2021
  • 6.10 COVID-19 IMPACT ON THE BIOSURGERY MARKET

7 BIOSURGERY MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
    • TABLE 13 BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
  • 7.2 BONE-GRAFT SUBSTITUTES
    • TABLE 14 BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 15 BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.1 DEMINERALIZED BONE MATRIX
      • 7.2.1.1 DBM is used extensively as a void filler in joint reconstruction and spinal fusion procedures
    • TABLE 16 MAJOR PRODUCTS IN THE DBM MARKET
    • TABLE 17 DEMINERALIZED BONE MATRIX MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.2 SYNTHETIC BONE GRAFTS
      • 7.2.2.1 Development of standard materials for synthetic bone grafts to drive the growth of this market segment
    • TABLE 18 MAJOR PRODUCTS IN THE SYNTHETIC BONE GRAFTS MARKET
    • TABLE 19 SYNTHETIC BONE GRAFTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.3 BONE MORPHOGENETIC PROTEINS
      • 7.2.3.1 Regulatory approval for the use of BMP in spinal fusion procedures to drive the growth of this market segment
    • TABLE 20 MAJOR PRODUCTS IN THE BONE MORPHOGENETIC PROTEINS MARKET
    • TABLE 21 BONE MORPHOGENETIC PROTEINS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.4 OTHER BONE-GRAFT SUBSTITUTES
    • TABLE 22 MAJOR PRODUCTS IN THE OTHER BONE-GRAFT SUBSTITUTES MARKET
    • TABLE 23 OTHER BONE-GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 SOFT-TISSUE ATTACHMENTS
    • TABLE 24 BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 25 BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.1 SYNTHETIC MESHES
      • 7.3.1.1 Vendors are focusing on developing new composite synthetic meshes to gain a competitive edge
    • TABLE 26 MAJOR PRODUCTS IN THE SYNTHETIC MESHES MARKET
    • TABLE 27 SYNTHETIC MESHES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.2 BIOLOGICAL MESHES
    • TABLE 28 MAJOR PRODUCTS IN THE BIOLOGICAL MESHES MARKET
    • TABLE 29 BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 30 BIOLOGICAL MESHES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.3.2.1 Allografts
        • 7.3.2.1.1 Advancements in deriving products from new allograft sources to drive market growth
    • TABLE 31 ALLOGRAFTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.3.2.2 Xenografts
        • 7.3.2.2.1 Efficacy of xenografts against allografts is not proven
    • TABLE 32 XENOGRAFTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.4 HEMOSTATIC AGENTS
    • TABLE 33 MAJOR PRODUCTS IN THE HEMOSTATIC AGENTS MARKET
    • TABLE 34 BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 35 BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.4.1 THROMBIN-BASED HEMOSTATIC AGENTS
      • 7.4.1.1 Developments in recombinant thrombin products to support the growth of this market segment
    • TABLE 36 MAJOR PRODUCTS IN THE THROMBIN-BASED HEMOSTATIC AGENTS MARKET
    • TABLE 37 THROMBIN-BASED HEMOSTATIC AGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.4.2 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS
      • 7.4.2.1 Vendors are expanding the availability of their ORC-based hemostatic agents across untapped markets in APAC
    • TABLE 38 MAJOR PRODUCTS IN THE OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS MARKET
    • TABLE 39 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.4.3 COMBINATION HEMOSTATIC AGENTS
      • 7.4.3.1 Advancements in combination materials would contribute to the growth of this market segment
    • TABLE 40 MAJOR PRODUCTS IN THE COMBINATION HEMOSTATIC AGENTS MARKET
    • TABLE 41 COMBINATION HEMOSTATIC AGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.5 SURGICAL SEALANTS & ADHESIVES
    • TABLE 42 BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 43 BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.5.1 NATURAL/BIOLOGICAL SEALANTS & ADHESIVES
      • 7.5.1.1 Natural/biological sealants & adhesives, by type
    • TABLE 44 BIOSURGERY MARKET FOR NATURAL/BIOLOGICAL SEALANTS & ADHESIVES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 45 BIOSURGERY MARKET FOR NATURAL/BIOLOGICAL SEALANTS & ADHESIVES, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.5.1.1.1 Fibrin-based sealants & adhesives
          • 7.5.1.1.1.1 Fibrin-based sealants & adhesives to dominate the market during the forecast period
    • TABLE 46 MAJOR PRODUCTS IN THE FIBRIN-BASED SEALANTS & ADHESIVES MARKET
    • TABLE 47 FIBRIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.5.1.1.2 Collagen-based sealants & adhesives
          • 7.5.1.1.2.1 Low-cost and reduced risk of disease transmission are promoting the adoption of collagen-based sealants & adhesives
    • TABLE 48 MAJOR PRODUCTS IN THE COLLAGEN BASED-SEALANTS & ADHESIVES MARKET
    • TABLE 49 COLLAGEN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.5.1.1.3 Gelatin-based sealants & adhesives
          • 7.5.1.1.3.1 Combination products are creating promising growth opportunities for gelatin-based sealants & adhesives
    • TABLE 50 MAJOR PRODUCTS IN THE GELATIN BASED-SEALANTS & ADHESIVES MARKET
    • TABLE 51 GELATIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.5.1.1.4 Albumin-based sealants
          • 7.5.1.1.4.1 Adoption of albumin-based sealants & adhesives is increasing in cardiovascular and cardiothoracic procedures
    • TABLE 52 MAJOR PRODUCTS IN THE ALBUMIN BASED-SEALANTS & ADHESIVES MARKET
    • TABLE 53 ALBUMIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.5.1.1.5 Other natural/biological sealants & adhesives
    • TABLE 54 OTHER NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.5.1.2 Natural/biological sealants & adhesives, by origin
    • TABLE 55 NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
        • 7.5.1.2.1 Animal-based sealants & adhesives
          • 7.5.1.2.1.1 Animal-based sealants and adhesives are not intended for intravascular and cerebrovascular repair due to the risk of disease transfer
    • TABLE 56 ANIMAL-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.5.1.2.2 Human blood-based sealants & adhesives
          • 7.5.1.2.2.1 Human blood-based sealants are finding significant applications in endovascular and laparoscopic vascular procedures
    • TABLE 57 HUMAN BLOOD-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.5.2 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES
    • TABLE 58 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 59 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.5.2.1 PEG hydrogel-based sealants & adhesives
        • 7.5.2.1.1 Rapid sealing abilities of PEG hydrogels to drive their adoption in spinal surgeries
    • TABLE 60 MAJOR PRODUCTS IN THE PEG HYDROGEL-BASED SEALANTS & ADHESIVES MARKET
    • TABLE 61 PEG HYDROGEL-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.5.2.2 Cyanoacrylate-based sealants & adhesives
        • 7.5.2.2.1 Cyanoacrylate-based sealants are preferred in dermatology and plastic surgeries
    • TABLE 62 MAJOR PRODUCTS IN THE CYANOACRYLATE-BASED SEALANTS & ADHESIVES MARKET
    • TABLE 63 CYANOACRYLATE-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.5.2.3 Urethane-based sealants & adhesives
        • 7.5.2.3.1 Urethane-based sealants can be used across wet environments
    • TABLE 64 URETHANE-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.5.2.4 Other synthetic and semi-synthetic sealants & adhesives
    • TABLE 65 MAJOR PRODUCTS IN THE OTHER SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET
    • TABLE 66 OTHER SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.6 ADHESION BARRIERS
    • TABLE 67 BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 68 BIOSURGERY MARKET FOR ADHESION BARRIERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.6.1 SYNTHETIC ADHESION BARRIERS
    • TABLE 69 SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 70 SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.6.1.1 Hyaluronic acid-based adhesion barriers
        • 7.6.1.1.1 Hyaluronic acid-based adhesion barriers dominate the synthetic adhesion barriers market
    • TABLE 71 MAJOR PRODUCTS IN THE HYALURONIC ACID-BASED ADHESION BARRIERS MARKET
    • TABLE 72 HYALURONIC ACID-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.6.1.2 Regenerated cellulose-based adhesion barriers
        • 7.6.1.2.1 Regenerated cellulose-based adhesion barriers are finding increasing use in C-section surgeries
    • TABLE 73 MAJOR PRODUCTS IN THE REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET
    • TABLE 74 REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.6.1.3 PEG-based adhesion barriers
        • 7.6.1.3.1 Demand for PEG-based adhesion barriers is driven by the rising number of peritoneal and abdominal surgeries
    • TABLE 75 MAJOR PRODUCTS IN THE PEG-BASED ADHESION BARRIERS MARKET
    • TABLE 76 PEG-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.6.1.4 Other synthetic adhesion barriers
    • TABLE 77 MAJOR PRODUCTS IN THE OTHER SYNTHETIC ADHESION BARRIERS MARKET
    • TABLE 78 OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.6.2 NATURAL ADHESION BARRIERS
    • TABLE 79 NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 80 NATURAL ADHESION BARRIERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.6.2.1 Collagen and protein adhesion barriers
        • 7.6.2.1.1 Collagen and protein adhesion barriers to dominate the natural adhesion barriers market during the forecast period
    • TABLE 81 MAJOR PRODUCTS IN THE COLLAGEN AND PROTEIN ADHESION BARRIERS MARKET
    • TABLE 82 COLLAGEN AND PROTEIN ADHESION BARRIERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.6.2.2 Fibrin-based adhesion barriers
        • 7.6.2.2.1 Fibrin-based adhesion barriers are finding increasing applications in laparotomy procedures
    • TABLE 83 MAJOR PRODUCTS IN THE FIBRIN-BASED ADHESION BARRIERS MARKET
    • TABLE 84 FIBRIN-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.7 STAPLE-LINE REINFORCEMENT AGENTS
    • 7.7.1 RISING FOCUS ON SEALANTS AND HEMOSTATS MAY RESTRAIN THE GROWTH OF THIS MARKET
    • TABLE 85 MAJOR PRODUCTS IN THE STAPLE-LINE REINFORCEMENT AGENTS MARKET
    • TABLE 86 BIOSURGERY MARKET FOR STAPLE-LINE REINFORCEMENT AGENTS, BY COUNTRY, 2019-2026 (USD MILLION)

8 BIOSURGERY MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 87 BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 8.2 ORTHOPEDIC SURGERY
    • 8.2.1 ORTHOPEDIC SURGERY IS THE LARGEST APPLICATION SEGMENT FOR BIOSURGERY PRODUCTS
    • TABLE 88 BIOSURGERY MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 GENERAL SURGERY
    • 8.3.1 INCREASING NUMBER OF HERNIA REPAIR PROCEDURES TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
    • TABLE 89 BIOSURGERY MARKET FOR GENERAL SURGERY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.4 NEUROLOGICAL SURGERY
    • 8.4.1 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
    • TABLE 90 BIOSURGERY MARKET FOR NEUROLOGICAL SURGERY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.5 CARDIOVASCULAR SURGERY
    • 8.5.1 BIOSURGERY PRODUCTS ARE INCREASINGLY REPLACING CONVENTIONAL SUTURE-BASED METHODS IN CARDIOVASCULAR PROCEDURES
    • TABLE 91 BIOSURGERY MARKET FOR CARDIOVASCULAR SURGERY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.6 RECONSTRUCTIVE SURGERY
    • 8.6.1 SOFT-TISSUE ATTACHMENT PRODUCTS ARE FINDING INCREASING USE IN BREAST AUGMENTATION AND RECONSTRUCTIVE PROCEDURES
    • TABLE 92 BIOSURGERY MARKET FOR RECONSTRUCTIVE SURGERY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.7 GYNECOLOGICAL SURGERY
    • 8.7.1 BIOSURGERY PRODUCTS ARE OFFERING PROMISING POTENTIAL IN C-SECTION SURGERIES
    • TABLE 93 C-SECTION SURGERIES PER 1,000 BIRTHS (2018 OR LATEST AVAILABLE)
    • TABLE 94 BIOSURGERY MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.8 UROLOGICAL SURGERY
    • 8.8.1 USE OF BIOSURGERY PRODUCTS IN COMPLEX RECONSTRUCTIVE UROLOGICAL SURGERIES TO STIMULATE SEGMENT GROWTH
    • TABLE 95 BIOSURGERY MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.9 THORACIC SURGERY
    • 8.9.1 GROWTH IN THIS APPLICATION SEGMENT IS DRIVEN BY THE INCREASING INCIDENCE OF PULMONARY DISEASES AND LUNG CANCER
    • TABLE 96 BIOSURGERY MARKET FOR THORACIC SURGERY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.10 OTHER APPLICATIONS
    • TABLE 97 BIOSURGERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)

9 BIOSURGERY MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 98 BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.2 HOSPITALS
    • 9.2.1 HOSPITALS ARE THE LARGEST END USERS OF BIOSURGERY PRODUCTS
    • TABLE 99 BIOSURGERY MARKET FOR HOSPITALS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.3 CLINICS
    • 9.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS ARE ADVANTAGES OFFERED BY CLINICS OVER HOSPITALS
    • TABLE 100 BIOSURGERY MARKET FOR CLINICS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.4 OTHER END USERS
    • TABLE 101 BIOSURGERY MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)

10 BIOSURGERY MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 27 GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA PACIFIC ARE EMERGING HOTSPOTS
    • TABLE 102 BIOSURGERY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 28 NORTH AMERICA: BIOSURGERY MARKET SNAPSHOT
    • TABLE 103 NORTH AMERICA: BIOSURGERY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 104 NORTH AMERICA: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 105 NORTH AMERICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 106 NORTH AMERICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 107 NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 108 NORTH AMERICA: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 109 NORTH AMERICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 110 NORTH AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 111 NORTH AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 112 NORTH AMERICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 113 NORTH AMERICA: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 114 NORTH AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 115 NORTH AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 116 NORTH AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 117 NORTH AMERICA: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 US to dominate the North American biosurgery market during the forecast period
    • TABLE 118 US: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 119 US: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 120 US: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 121 US: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 122 US: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 123 US: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 US: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 125 US: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 126 US: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 127 US: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 128 US: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 US: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 US: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 131 US: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Growing geriatric population and the increasing volume of surgeries to drive the demand for biosurgery products in Canada
    • TABLE 132 CANADA: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 133 CANADA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 134 CANADA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 135 CANADA: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 136 CANADA: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 137 CANADA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 138 CANADA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 CANADA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 140 CANADA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 141 CANADA: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 142 CANADA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 CANADA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 CANADA: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 145 CANADA: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 146 EUROPE: BIOSURGERY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 147 EUROPE: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 148 EUROPE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 149 EUROPE: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 150 EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 151 EUROPE: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 152 EUROPE: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 153 EUROPE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 154 EUROPE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 155 EUROPE: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 156 EUROPE: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 157 EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 158 EUROPE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 159 EUROPE: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 160 EUROPE: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany dominated the European biosurgery market in 2020
    • TABLE 161 GERMANY: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 162 GERMANY: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 163 GERMANY: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 164 GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 165 GERMANY: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 166 GERMANY: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 167 GERMANY: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 168 GERMANY: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 169 GERMANY: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 170 GERMANY: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 171 GERMANY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 172 GERMANY: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 173 GERMANY: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 174 GERMANY: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Growing volume of hernia repair surgeries and cardiovascular surgeries in the UK stimulating market growth
    • TABLE 175 UK: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 176 UK: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 177 UK: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 178 UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 179 UK: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 180 UK: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 181 UK: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 182 UK: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 183 UK: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 184 UK: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 185 UK: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 186 UK: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 187 UK: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 188 UK: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Presence of a well-established healthcare system and growing geriatric population to boost market growth
    • TABLE 189 FRANCE: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 190 FRANCE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 191 FRANCE: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 192 FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 193 FRANCE: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 194 FRANCE: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 195 FRANCE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 196 FRANCE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 197 FRANCE: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 198 FRANCE: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 199 FRANCE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 200 FRANCE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 201 FRANCE: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 202 FRANCE: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Increasing volume of surgeries to drive the demand for biosurgery products in the country
    • TABLE 203 ITALY: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 204 ITALY: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 205 ITALY: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 206 ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 207 ITALY: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 208 ITALY: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 209 ITALY: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 210 ITALY: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 211 ITALY: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 212 ITALY: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 213 ITALY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 214 ITALY: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 215 ITALY: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 216 ITALY: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.5 SWITZERLAND
      • 10.3.5.1 Increasing public health insurance coverage to drive the number of surgical procedures
    • TABLE 217 SWITZERLAND: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 218 SWITZERLAND: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 219 SWITZERLAND: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 220 SWITZERLAND: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 221 SWITZERLAND: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 222 SWITZERLAND: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 223 SWITZERLAND: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 224 SWITZERLAND: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 225 SWITZERLAND: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 226 SWITZERLAND: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 227 SWITZERLAND: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 228 SWITZERLAND: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 229 SWITZERLAND: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 230 SWITZERLAND: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Growing healthcare budget and rising efforts for boosting the local manufacturing of medical products to drive market growth
    • TABLE 231 SPAIN: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 232 SPAIN: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 233 SPAIN: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 234 SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 235 SPAIN: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 236 SPAIN: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 237 SPAIN: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 238 SPAIN: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 239 SPAIN: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 240 SPAIN: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 241 SPAIN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 242 SPAIN: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 243 SPAIN: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 244 SPAIN: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 245 ROE: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 246 ROE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 247 ROE: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 248 ROE: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 249 ROE: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 250 ROE: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 251 ROE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 252 ROE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 253 ROE: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 254 ROE: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 255 ROE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 256 ROE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 257 ROE: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 258 ROE: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 29 APAC: BIOSURGERY MARKET SNAPSHOT
    • TABLE 259 ASIA PACIFIC: BIOSURGERY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 260 ASIA PACIFIC: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 261 ASIA PACIFIC: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 262 ASIA PACIFIC: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 263 ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 264 ASIA PACIFIC: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 265 ASIA PACIFIC: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 266 ASIA PACIFIC: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 267 ASIA PACIFIC: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 268 ASIA PACIFIC: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 269 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 270 ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 271 ASIA PACIFIC: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 272 ASIA PACIFIC: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 273 ASIA PACIFIC: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Strong healthcare system and rising geriatric population to support market growth in Japan
    • TABLE 274 JAPAN: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 275 JAPAN: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 276 JAPAN: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 277 JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 278 JAPAN: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 279 JAPAN: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 280 JAPAN: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 281 JAPAN: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 282 JAPAN: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 283 JAPAN: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 284 JAPAN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 285 JAPAN: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 286 JAPAN: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 287 JAPAN: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Growing number of hospitals and healthcare policy reforms stimulating the growth of the biosurgery market
    • TABLE 288 CHINA: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 289 CHINA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 290 CHINA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 291 CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 292 CHINA: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 293 CHINA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 294 CHINA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 295 CHINA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 296 CHINA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 297 CHINA: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 298 CHINA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 299 CHINA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 300 CHINA: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 301 CHINA: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Rising healthcare awareness and favorable government support to stimulate market growth in India
    • TABLE 302 INDIA: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 303 INDIA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 304 INDIA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 305 INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 306 INDIA: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 307 INDIA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 308 INDIA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 309 INDIA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 310 INDIA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 311 INDIA: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 312 INDIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 313 INDIA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 314 INDIA: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 315 INDIA: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Growing number of cosmetic surgeries to drive the demand for surgical sealants and soft-tissue attachment products in South Korea
    • TABLE 316 SOUTH KOREA: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 317 SOUTH KOREA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 318 SOUTH KOREA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 319 SOUTH KOREA: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 320 SOUTH KOREA: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 321 SOUTH KOREA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 322 SOUTH KOREA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 323 SOUTH KOREA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 324 SOUTH KOREA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 325 SOUTH KOREA: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 326 SOUTH KOREA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 327 SOUTH KOREA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 328 SOUTH KOREA: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 329 SOUTH KOREA: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 330 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 331 REST OF ASIA PACIFIC: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 332 REST OF ASIA PACIFIC: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 333 REST OF ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 334 REST OF ASIA PACIFIC: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 335 REST OF ASIA PACIFIC: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 336 REST OF ASIA PACIFIC: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 337 REST OF ASIA PACIFIC: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 338 REST OF ASIA PACIFIC: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 339 REST OF ASIA PACIFIC: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 340 REST OF ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 341 REST OF ASIA PACIFIC: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 342 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 343 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 344 LATIN AMERICA: BIOSURGERY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 345 LATIN AMERICA: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 346 LATIN AMERICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 347 LATIN AMERICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 348 LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 349 LATIN AMERICA: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 350 LATIN AMERICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 351 LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 352 LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 353 LATIN AMERICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 354 LATIN AMERICA: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 355 LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 356 LATIN AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 357 LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 358 LATIN AMERICA: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Brazil accounted for the largest share of the LATAM market in 2020
    • TABLE 359 BRAZIL: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 360 BRAZIL: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 361 BRAZIL: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 362 BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 363 BRAZIL: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 364 BRAZIL: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 365 BRAZIL: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 366 BRAZIL: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 367 BRAZIL: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 368 BRAZIL: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 369 BRAZIL: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 370 BRAZIL: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 371 BRAZIL: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 372 BRAZIL: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Low-cost surgeries are driving medical tourism in Mexico
    • TABLE 373 MEXICO: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 374 MEXICO: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 375 MEXICO: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 376 MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 377 MEXICO: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 378 MEXICO: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 379 MEXICO: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 380 MEXICO: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 381 MEXICO: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 382 MEXICO: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 383 MEXICO: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 384 MEXICO: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 385 MEXICO: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 386 MEXICO: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 387 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 388 REST OF LATIN AMERICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 389 REST OF LATIN AMERICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 390 REST OF LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 391 REST OF LATIN AMERICA: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 392 REST OF LATIN AMERICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 393 REST OF LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 394 REST OF LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 395 REST OF LATIN AMERICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 396 REST OF LATIN AMERICA: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 397 REST OF LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 398 REST OF LATIN AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 399 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 400 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.6 MIDDLE EAST AND AFRICA
    • 10.6.1 MEA IS THE SMALLEST REGIONAL MARKET FOR BIOSURGERY PRODUCTS
    • TABLE 401 MIDDLE EAST AND AFRICA: BIOSURGERY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 402 MIDDLE EAST AND AFRICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 403 MIDDLE EAST AND AFRICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 404 MIDDLE EAST AND AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 405 MIDDLE EAST AND AFRICA: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 406 MIDDLE EAST AND AFRICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 407 MIDDLE EAST AND AFRICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 408 MIDDLE EAST AND AFRICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019-2026 (USD MILLION)
    • TABLE 409 MIDDLE EAST AND AFRICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 410 MIDDLE EAST AND AFRICA: ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 411 MIDDLE EAST AND AFRICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 412 MIDDLE EAST AND AFRICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 413 MIDDLE EAST AND AFRICA: BIOSURGERY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 414 MIDDLE EAST AND AFRICA: BIOSURGERY MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES
  • 11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
  • 11.4 MARKET SHARE ANALYSIS
    • 11.4.1 SURGICAL SEALANTS AND ADHESIVES
    • FIGURE 31 SURGICAL SEALANTS AND ADHESIVES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
    • 11.4.2 HEMOSTATIC AGENTS
    • FIGURE 32 HEMOSTATIC AGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
    • 11.4.3 BONE-GRAFT SUBSTITUTES
    • FIGURE 33 BONE-GRAFT SUBSTITUTES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
    • 11.4.4 ADHESION BARRIERS
    • FIGURE 34 ADHESION BARRIERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
    • 11.4.5 SOFT-TISSUE ATTACHMENTS
    • FIGURE 35 SOFT-TISSUE ATTACHMENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
  • 11.5 COMPETITIVE BENCHMARKING
    • 11.5.1 FOOTPRINT OF COMPANIES IN THE BIOSURGERY MARKET
    • TABLE 415 PRODUCT FOOTPRINT OF COMPANIES (25 MARKET PLAYERS)
    • TABLE 416 REGIONAL FOOTPRINT OF COMPANIES (25 MARKET PLAYERS)
  • 11.6 COMPETITIVE LEADERSHIP MAPPING
    • 11.6.1 STARS
    • 11.6.2 EMERGING LEADERS
    • 11.6.3 PERVASIVE PLAYERS
    • 11.6.4 PARTICIPANTS
    • FIGURE 36 BIOSURGERY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
  • 11.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 DYNAMIC COMPANIES
    • 11.7.3 STARTING BLOCKS
    • 11.7.4 RESPONSIVE COMPANIES
    • FIGURE 37 BIOSURGERY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020)
  • 11.8 COMPETITIVE SCENARIO
    • 11.8.1 PRODUCT LAUNCHES & APPROVALS
    • 11.8.2 DEALS
    • 11.8.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 12.1.1 BAXTER INTERNATIONAL INC.
    • TABLE 420 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW
    • FIGURE 38 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020)
    • 12.1.2 B. BRAUN MELSUNGEN AG
    • TABLE 421 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
    • FIGURE 39 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)
    • 12.1.3 BECTON, DICKINSON & COMPANY
    • TABLE 422 BECTON, DICKINSON & COMPANY: BUSINESS OVERVIEW
    • FIGURE 40 BECTON, DICKINSON & COMPANY: COMPANY SNAPSHOT (2020)
    • 12.1.4 JOHNSON & JOHNSON
    • TABLE 423 JOHNSON & JOHNSON: BUSINESS OVERVIEW
    • FIGURE 41 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
    • 12.1.5 MEDTRONIC PLC
    • TABLE 424 MEDTRONIC PLC: BUSINESS OVERVIEW
    • FIGURE 42 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
    • 12.1.6 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
    • TABLE 425 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 43 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.7 COMMONWEALTH SERUM LABORATORIES LIMITED
    • TABLE 426 COMMONWEALTH SERUM LABORATORIES LIMITED: BUSINESS OVERVIEW
    • FIGURE 44 COMMONWEALTH SERUM LABORATORIES LIMITED: COMPANY SNAPSHOT (2020)
    • 12.1.8 HEMOSTASIS LLC
    • TABLE 427 HEMOSTASIS LLC: BUSINESS OVERVIEW
    • 12.1.9 PFIZER INC.
    • TABLE 428 PFIZER INC.: BUSINESS OVERVIEW
    • FIGURE 45 PFIZER INC.: COMPANY SNAPSHOT (2020)
    • 12.1.10 STRYKER CORPORATION
    • TABLE 429 STRYKER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 46 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.11 CRYOLIFE, INC.
    • TABLE 430 CRYOLIFE, INC.: BUSINESS OVERVIEW
    • FIGURE 47 CRYOLIFE, INC.: COMPANY SNAPSHOT (2020)
    • 12.1.12 ZIMMER BIOMET
    • TABLE 431 ZIMMER BIOMET: BUSINESS OVERVIEW
    • FIGURE 48 ZIMMER BIOMET: COMPANY SNAPSHOT (2020)
    • 12.1.13 KUROS BIOSCIENCES AG
    • TABLE 432 KUROS BIOSCIENCES AG: BUSINESS OVERVIEW
    • FIGURE 49 KUROS BIOSCIENCES AG: COMPANY SNAPSHOT (2020)
    • 12.1.14 ORTHOFIX MEDICAL INC.
    • TABLE 433 ORTHOFIX MEDICAL INC.: BUSINESS OVERVIEW
    • FIGURE 50 ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT (2020)
    • 12.1.15 SMITH & NEPHEW PLC
    • TABLE 434 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
    • FIGURE 51 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020)
    • 12.1.16 TISSUE REGENIX GROUP PLC
    • TABLE 435 TISSUE REGENIX GROUP PLC: BUSINESS OVERVIEW
    • FIGURE 52 TISSUE REGENIX GROUP PLC: COMPANY SNAPSHOT (2020)
    • 12.1.17 BETATECH MEDICAL
    • TABLE 436 BETATECH MEDICAL: BUSINESS OVERVIEW
    • 12.1.18 MERIL LIFE SCIENCES PVT. LTD.
    • TABLE 437 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW
    • 12.1.19 RTI SURGICAL
    • TABLE 438 RTI SURGICAL: BUSINESS OVERVIEW
    • 12.1.20 SAMYANG HOLDINGS CORPORATION
    • TABLE 439 SAMYANG HOLDINGS CORPORATION: BUSINESS OVERVIEW
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 AROA BIOSURGERY LTD.
    • 12.2.2 MEYER-HAAKE GMBH
    • 12.2.3 BIOM'UP
    • 12.2.4 BIOCER ENTWICKLUNGS-GMBH
    • 12.2.5 HANNOX INTERNATIONAL CORP.

13 APPENDIX

  • 13.1 INSIGHTS OF INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 AVAILABLE CUSTOMIZATIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS